Mylan Loses Appeal to Quash Patent for Epilepsy Drug Vimpat (1) Bloomberg Law
Mylan Pharmaceuticals Inc. and two other generic drug makers have failed for the second time to kill a patent that prohibits them from making a generic version …
Mylan Loses Appeal to Quash Patent for Epilepsy Drug Vimpat (1) Bloomberg Law
Mylan Pharmaceuticals Inc. and two other generic drug makers have failed for the second time to kill a patent that prohibits them from making a generic version …